Buy ScyFIX 700 and Accessories on-line

Welcome to ScyFIX web shop where you can order ScyFIX MCN products, choose payment method, including a secure on-line credit card payment service (SSL), and check your delivery status on-line. Buying on-line is safe and easy and you will be guided all the way. All prices are in € (Euro). Place your order and your credit card company will convert the amount in € to your own currency. We accept Visa, Master Card, EuroCard and most bank cards connected to VISA or Master Card. Follow the instructions to take you through the pages, and then onto a secure site in which you will input your credit card and shipping details. When bank authorization has been attained, you will be get a confirmation on-line, as well as a confirming e-mail. If at any stage you wish to change your order, just click the "Remove"-button.

All customers who have bought the ScyFIX 600 device are offered to upgrade to the 700 system at a discount.

Sales of the ScyFIX products is administered by ScyFIX general agent Prospectus AB, Stockholm, Sweden (EU). For any ScyFIX product or customer service questions, please contact Prospectus. If you are a US resident and want to know more about our therapy, please send an inquiry by e-mail to our European office support@scyfix.org.

For current exchange rates we recommend the web site www.oanda.com.

 

ScyFIX 700 - Upgrade for ScyFIX 600 Users - 1000 € discount

ScyFIX 600 users are offered an upgrade to the ScyFIX 700 MCN system at a discount of 1000 € compared to ordinary price, if purchased in advance with a money back guarantee before February 28, 2011. 3000 Euro will be refunded if patient experiences negative results. Purchase now and you will become one of the first to benefit from this new revolutionary technology. The ScyFIX 700 is planned for delivery in March 2011. The ScyFIX 700 Therapy Kit includes a ScyFIX 700 micro current neuromodulator, wires, 24 sets of pads with electrodes (approx. one year's usage), AC/DC adapters for EU or UK or USA, and an instruction manual in English. From March1:st 2011 the price for an upgrade will be 3990 €.
Price: 3490€ Add to cart

  ScyFIX 700 - New patients - 500 € discount

New customers are offered to buy the ScyFIX 700 MCN system at a discount of 500 € compared to ordinary price, if purchased in advance with a money back guarantee before February 28, 2011. 3500 Euro will be refunded if patient experiences negative results. Purchase now and you will become one of the first to benefit from this new revolutionary technology. The ScyFIX 700 is planned for delivery in March 2011. The ScyFIX 700 Therapy Kit includes a ScyFIX 700 micro current neuromodulator, wires, 24 sets of pads with electrodes (approx. one year's usage), AC/DC adapters for EU or UK or USA, and an instruction manual in English. From March 1:st 2011 the price will be 4490 €.
Price: 3990€ Add to cart

Pads

Price for 24 sets of pads. Each set of pads normally lasts 2-4 weeks.
Price: 290€ Add to cart

  US and UK AC/DC Adaptor

AC/DC Adaptors for US and UK standard sockets. (European EU adaptor is included as standard.)
Price: 70€ Add to cart

Lead wires

Replacement lead wires to connect pads with device.
Price: 30€ Add to cart

 

 

Your cart

Your cart is empty

 

Information

The above prices are only valid for direct sale to patients over the web shop. Air Mail shipping is included in all prices. Products will be shipped from Prospectus AB (global distributor of ScyFIX products) within seven (7) days from the day that full payment has been received. Any other costs, e.g. Customs/ Import/ Entry Duty or Taxes, VAT and other locally imposed duties or taxes in the buyer's Country, will be additional and have to be paid for locally by the buyer.

 
     

Breaking News! The ScyFIX 700 MCN Therapy is the only patented Micro Current Neuromodulation (MCN) device approved in Europe for the treatment of Retinitis Pigmentosa. Compelling Clinical Results: Retinitis Pigmentosa (RETINITIS PIGMENTOSA) and our Dry Age-Related Macular Degeneration (“ARMD”) are degenerative diseases, and improvement in visual fields, visual acuity, or contrast sensitivity is not expected. Data through twenty-four months suggests that MCN therapy is clinically effective. The data reflects that MCN therapy has not only slowed down the progression of disease symptoms as intended, but has in many cases halted, and in some cases reversed the progression of the diseases.
Patients are now using mobile phones, reading newspapers, seeing faces of family members and threading needles, none of these day to day activities were possible for these patients before using the ScyFIX MCN device. Similar compelling results have been achieved in our Dry Age-Related Macular Degeneration (“ARMD”) trial as well.